Provenance Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$2.11K | – | 554 |
|
|
2025
Q1 | $2.11K | Hold |
16
| – | – | ﹤0.01% | 401 |
|
|
2024
Q4 | $1.34K | Hold |
16
| – | – | ﹤0.01% | 468 |
|
|
2024
Q3 | $1.17K | Hold |
16
| – | – | ﹤0.01% | 515 |
|
|
2024
Q2 | $1.1K | Hold |
16
| – | – | ﹤0.01% | 436 |
|
|
2024
Q1 | $1.11K | Hold |
16
| – | – | ﹤0.01% | 467 |
|
|
2023
Q4 | $1.15K | Sell |
16
-1
| -6% | -$72 | ﹤0.01% | 516 |
|
|
2023
Q3 | $886 | Buy |
+17
| New | +$886 | ﹤0.01% | 422 |
|